Clinical Trial Update: the Efficacy and Safety of HRS9531 Injection in Subjects With Type 2 Diabetes， Inadequately Controlled With Diet and Exercise Alone [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating the efficacy and safety of HRS9531 injection in adults with Type 2 diabetes inadequately controlled by diet and exercise.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HRS9531

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: ACTIVE_NOT_RECRUITING